Found: 14
Select item for more details and to access through your institution.
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30681-1
- By:
- Publication type:
- Article
Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 417, doi. 10.3390/vaccines11020417
- By:
- Publication type:
- Article
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy.
- Published in:
- Journal of Molecular Medicine, 2012, v. 90, n. 8, p. 959, doi. 10.1007/s00109-012-0863-6
- By:
- Publication type:
- Article
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.
- Published in:
- Journal of Molecular Medicine, 2011, v. 89, n. 11, p. 1113, doi. 10.1007/s00109-011-0777-8
- By:
- Publication type:
- Article
Mature T-cell Lymphomagenesis Induced by Retroviral Insertional Activation of Janus Kinase 1.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 6, p. 1160, doi. 10.1038/mt.2013.67
- By:
- Publication type:
- Article
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1130539
- By:
- Publication type:
- Article
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1130539
- By:
- Publication type:
- Article
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.
- Published in:
- Science Immunology, 2022, v. 7, n. 78, p. 1, doi. 10.1126/sciimmunol.ade9888
- By:
- Publication type:
- Article
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5.
- Published in:
- Science Immunology, 2022, v. 7, n. 77, p. 1, doi. 10.1126/sciimmunol.ade2283
- By:
- Publication type:
- Article
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.
- Published in:
- Science Immunology, 2022, v. 7, n. 75, p. 1, doi. 10.1126/sciimmunol.abq2427
- By:
- Publication type:
- Article
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00127
- By:
- Publication type:
- Article
Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6246, doi. 10.1038/ncomms7246
- By:
- Publication type:
- Article
Comparison of three humanized mouse models for adoptive T cell transfer.
- Published in:
- Journal of Gene Medicine, 2012, v. 14, n. 8, p. 540, doi. 10.1002/jgm.2652
- By:
- Publication type:
- Article
BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00462-4
- By:
- Publication type:
- Article